Compare ADAM & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADAM | AVNS |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 634.9M | 521.7M |
| IPO Year | N/A | N/A |
| Metric | ADAM | AVNS |
|---|---|---|
| Price | $7.48 | $11.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 578.8K | 523.4K |
| Earning Date | 10-29-2025 | 11-05-2025 |
| Dividend Yield | ★ 12.33% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | $216,781,000.00 | ★ $699,900,000.00 |
| Revenue This Year | $13.60 | $3.07 |
| Revenue Next Year | $49.42 | $2.16 |
| P/E Ratio | $38.51 | ★ N/A |
| Revenue Growth | N/A | ★ 2.70 |
| 52 Week Low | $5.02 | $9.30 |
| 52 Week High | $7.75 | $19.18 |
| Indicator | ADAM | AVNS |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 45.17 |
| Support Level | N/A | $10.84 |
| Resistance Level | N/A | $12.34 |
| Average True Range (ATR) | 0.00 | 0.45 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 0.00 | 23.67 |
Adamas Trust Inc is an internally-managed REIT for U.S. federal income tax purposes, in the business of acquiring, investing in, financing and managing primarily mortgage-related single-family and multi-family residential assets. Its objective is to deliver long-term stable distributions to its stockholders over changing economic conditions through a combination of net interest spread and capital gains from a diversified investment portfolio. The company's investment portfolio includes credit sensitive single-family and multi-family assets.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.